Responsible Side Effects Management in Oncology

CompletedOBSERVATIONAL
Enrollment

267

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

September 5, 2017

Study Completion Date

September 5, 2017

Conditions
PharmacovigilanceOncologyAntineoplastic Treatment
Trial Locations (1)

10 000

UHC Sestre milorsdnice, Zagreb

All Listed Sponsors
lead

University Hospital Sestre Milosrdnice

OTHER

NCT04623437 - Responsible Side Effects Management in Oncology | Biotech Hunter | Biotech Hunter